Clinical Trial Update: Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ospemifene for vaginal dryness due to menopause has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-related Vaginal Dryness

Drugs mentioned

• Ospemifene (ospemifene)

Snippet

Sponsor: Shionogi | Conditions: Vaginal Dryness | Phase 3 | Status: COMPLETED | Results posted: 2019-04-02